These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 37692967)

  • 21. Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues.
    Kakoti BB; Bezbaruah R; Ahmed N
    Front Pharmacol; 2022; 13():1007315. PubMed ID: 36263141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
    Gelosa P; Castiglioni L; Camera M; Sironi L
    Biochem Pharmacol; 2020 Jul; 177():113895. PubMed ID: 32145263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translational and clinical pharmacology considerations in drug repurposing for X-linked adrenoleukodystrophy-A rare peroxisomal disorder.
    Tieu JH; Sahasrabudhe SA; Orchard PJ; Cloyd JC; Kartha RV
    Br J Clin Pharmacol; 2022 Jun; 88(6):2552-2563. PubMed ID: 34558098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug repurposing in rare diseases: Myths and reality.
    Fetro C; Scherman D
    Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov.
    Su EW; Sanger TM
    PeerJ; 2017; 5():e3154. PubMed ID: 28348935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions.
    Fu L; Jin W; Zhang J; Zhu L; Lu J; Zhen Y; Zhang L; Ouyang L; Liu B; Yu H
    Acta Pharm Sin B; 2022 Feb; 12(2):532-557. PubMed ID: 35256933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields.
    Natsheh IY; Alsaleh MM; Alkhawaldeh AK; Albadawi DK; Darwish MM; Shammout MJA
    Drug Target Insights; 2024; 18():8-19. PubMed ID: 38751378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
    Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
    J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repurposed drug candidates for antituberculosis therapy.
    An Q; Li C; Chen Y; Deng Y; Yang T; Luo Y
    Eur J Med Chem; 2020 Apr; 192():112175. PubMed ID: 32126450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Artificial Intelligence in COVID-19 drug repurposing.
    Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S
    Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Drug Repurposing: Focus on Vasodilators.
    Ribeiro E; Costa B; Vasques-Nóvoa F; Vale N
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work.
    Kumar R; Harilal S; Gupta SV; Jose J; Thomas Parambi DG; Uddin MS; Shah MA; Mathew B
    Eur J Med Chem; 2019 Nov; 182():111602. PubMed ID: 31421629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Repurposing: Claiming the Full Benefit from Drug Development.
    Kort E; Jovinge S
    Curr Cardiol Rep; 2021 May; 23(6):62. PubMed ID: 33961142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Repurposing: Exploring Potential Anti-Cancer Strategies by Targeting Cancer Signalling Pathways.
    Haddad N; Gamaethige SM; Wehida N; Elbediwy A
    Biology (Basel); 2024 May; 13(6):. PubMed ID: 38927266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug repurposing: a promising tool to accelerate the drug discovery process.
    Parvathaneni V; Kulkarni NS; Muth A; Gupta V
    Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2.
    Niranjan V; Setlur AS; Karunakaran C; Uttarkar A; Kumar KM; Skariyachan S
    Struct Chem; 2022; 33(5):1585-1608. PubMed ID: 35938064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden.
    Bai JPF
    J Pharm Sci; 2016 Oct; 105(10):3007-3012. PubMed ID: 27522921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases.
    Liu W; Wang G; Wang Z; Wang G; Huang J; Liu B
    Drug Discov Today; 2022 Jul; 27(7):1994-2007. PubMed ID: 35395400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.